LITHIUM OLIGOSOL, oral solution in an ampoule or in a single-dose container 28 ampoules of 2 ml
Active ingredients: Lithium gluconate, Lithium
Commercialized according to BDPM
Oral solution28 ampoules of 2 mlorale;sublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LITHIUM OLIGOSOL, solution buvable en ampoule ou en récipient unidose
- Pharmaceutical form
- solution buvable ou
- Route of administration
- orale;sublinguale
- Presentation description
- 28 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- LABCATAL
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 29 Jan 2007
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63672890CIP73754662CIP133400937546621Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GLUCONATE DE LITHIUMsolution | 8,1400 mg · une ampoule ou un récipient unidose de 2 ml | SA |
| LITHIUMsolution | 0,2796 mg · une ampoule ou un récipient unidose de 2 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.